Profound Medical Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Profound Medical's estimated annual revenue is currently $56.2M per year.(i)
  • Profound Medical's estimated revenue per employee is $251,000

Employee Data

  • Profound Medical has 224 Employees.(i)
  • Profound Medical grew their employee count by 29% last year.

Profound Medical's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Commercial OfficerReveal Email/Phone
3
Chief Architect and VP Software DevelopmentReveal Email/Phone
4
VP Business DevelopmentReveal Email/Phone
5
SVPReveal Email/Phone
6
VP Business DevelopmentReveal Email/Phone
7
VP Product Management & RAReveal Email/Phone
8
VP, Product DevelopmentReveal Email/Phone
9
SVP Product Leader (TULSA-PRO)Reveal Email/Phone
10
Director, Market Access, Profound MedicalReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$32.4M1294%N/AN/A
#2
$3.8M15-6%N/AN/A
#3
$95.6M3819%N/AN/A
#4
$23.8M953%N/AN/A
#5
$12.8M5138%N/AN/A
#6
$91.9M2934%$53.9MN/A
#7
$326.6M130113%N/AN/A
#8
$36.6M0N/A$1.3BN/A
#9
$22.1M88-28%N/AN/A
#10
$8.5M340%N/AN/A
Add Company

What Is Profound Medical?

AN INSIDE OUT APPROACH TO PROSTATE ABLATION\r\n\r\nProfound Medical is a Canadian medical device company that has developed a unique and minimally invasive procedure to ablate the prostate gland in prostate cancer patients. \r\n\r\nProfound’s novel technology combines real-time MR imaging with transurethral therapeutic ultrasound and closed-loop thermal feedback control. It provides a highly precise treatment tailored to patient-specific anatomy and pathology. This method of prostate ablation offers short treatment times and low morbidity, allowing for fast patient recovery. \r\n\r\nFor more information, visit profoundmedical.com

keywords:N/A

N/A

Total Funding

224

Number of Employees

$56.2M

Revenue (est)

29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Profound Medical News

2022-04-17 - Financial Contrast: LENSAR (NASDAQ:LNSR) and Profound ...

Profound Medical is trading at a lower price-to-earnings ratio than LENSAR, indicating that it is currently the more affordable of the two...

2022-04-17 - Profound Medical (NASDAQ:PROF) PT Set at $22.00 by ...

Profound Medical (NASDAQ:PROF – Get Rating) has been given a $22.00 target price by equities research analysts at Raymond James in a...

2022-04-13 - Profound Medical to Release First Quarter 2022 Financial ...

(NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$62.3M2240%N/A
#2
$67.1M22628%N/A
#3
$88.9M229-2%N/A
#4
$15M2316%N/A
#5
$57.9M23219%N/A